Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development

Novel tuberculosis (TB) drug regimens are urgently needed, and their development will be enabled by improved preclinical approaches that more effectively inform and ensure safe selection of clinical candidates and drug combination/regimens. An evidence-based approach for the assessment of nonclinica...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Nuermberger, Eric, Sizemore, Christine, Romero, Klaus, Hanna, Debra
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2016
Subjects:
Commentary
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775974/
https://ncbi.nlm.nih.gov/pubmed/26824941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02041-15
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items